Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 5:05 PM
Ignite Modification Date: 2025-12-24 @ 5:05 PM
NCT ID: NCT05906550
Eligibility Criteria: Inclusion Criteria: 1. Adult patients aged 18 years or older. 2. End-stage renal disease with unlikely recovery of kidney function according to the attending nephrologist. 3. Arteriovenous fistula or arteriovenous graft as hemodialysis vascular access that fulfills both of the following criteria at the time of trial enrollment: 1. Vascular access flow volume of at least 500mL/min; and 2. Functional vascular access: the vascular access was cannulated with 2 needles and achieved the prescribed access circuit flow in at least 6 dialysis sessions over the past 30 days. Patients who have single needle hemodialysis for reasons other than vascular access dysfunction (e.g. for nocturnal hemodialysis) but who can be cannulated with 2 needles for flow measurements and fulfill the other requirements for a functional vascular access can be enrolled as well. 4. Planning to remain in one of the participating dialysis centers for at least 1 year. Exclusion Criteria: 1. Arteriovenous fistulas with multiple venous outflow paths upstream of the cannulation sites, that are not suitable for flow volume measurements using ultrasound dilution (e.g. Gracz fistulas and Ellipsys or WavelinQ endovascular fistulas). 2. Home hemodialysis. 3. Thrombosis of the current vascular access in the past year. 4. Planned access-related intervention. 5. Living donor kidney transplantation, switch to peritoneal dialysis, or switch to home hemodialysis planned within 6 months. 6. Life expectancy of less than 6 months, in the opinion of the attending nephrologist. 7. Unable to provide informed consent.
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Study: NCT05906550
Study Brief:
Protocol Section: NCT05906550